Abstrak
Endometriosis is still believed as the presence of an endometrium-like tissue outside of the uterine cavity. It is a common gynecological condition affecting 1 in 10 women in the reproductive age group. 1 Its incidence increases to 20% in patients with infertility and up to 30% in patients with chronic pelvic pain. 2 Furthermore, endometriosis develops mostly in women of reproductive age and regresses after menopause or ovariectomy, suggesting that its existence is influenced by ovarian steroid hormones (estrogen and progesterone). Estrogen leads to the process of growth (estrogendependent), 3 while progesterone facilitates the process of suppression or shrinkage of the endometriotic tissues.
Although the etiology and the exact mechanism for the development of endometriosis are still unresolved, there is a large body of laboratory and circumstantial evidence that suggests an important role for estrogen in the establishment and maintenance of this disease. On the other hand, proliferation and differentiation of the human endometrium are also controlled by ovarian sex steroids. Estrogen stimulates the proliferation of both glandular and stromal cells, whereas progesterone inhibits the growth of glandular cells and induces decidual changes in stromal cells. 4 Hormone-induced proliferation and differentiation of the endometrium have been investigated from various aspects, including up-and down-regulation of steroid receptors. 4, 5 The sex steroid-induced events are generally believed to occur via estrogen receptors (ER) and progesterone receptors (PR), which eventually promote the transcription of target genes. 5 The existence of sex steroid hormone receptors, either in endometrium or endometriosis, can be detected by using either semiquantitative but more specific (such as immunohistochemistry) or quantitative (such as enzyme immunosorbent assay) methods. Using those both techniques, endometriosis tissue had also been demonstrated to express estrogen and progesterone receptors. 6, 7 These receptors have showed heterogeneity of different sites. 8 Despite a sensitive and specific tool, the semi-quantitative technique does not measure the receptor concentration in the endometriotic tissue, which can even be used as a quantitative parameter of responsivity to the medical treatment given.
When the response of the steroid sex-dependent tissues to hormonal therapy is concerned, it is clearly seen that indicators of the response of endometrial tissue to ovarian steroid hormones were different between endometrium and endometriosis. Histological and ultrastructural studies have demonstrated that endometriosis responded in an incomplete and variable fashion, compared with endometrium, to cyclic estrogen and progesterone stimulation and also to hormonal therapy. 9, 10 The dependency of endometriosis on sex steroid hormones has rationalized to use drugs for endometriosis treatment those with the ability in modulating or in opposing the action of those sex hormones. Frequently, despite maximal hormonal treatment, however, a good response is failed to achieve. It may be caused by either the presence or absence and the content of estrogen and progesterone receptors in those abnormal tissues.
The objective of this study was to measure the concentration of estrogen and progesterone receptors and to compare their concentration between those in the normal and those in endometriotic tissues according to the anatomical topographic location of internal genital organ. This investigation was designed as a cross-sectional and analytical study.
METHODS

Subject selection
This study was conducted from February 1995 until July 1996 at the Budhi Jaya Maternity Hospital, Jakarta (as sample collecting site) and the Endocrine Laboratory, Research Center for Immunoendocrinology, Faculty of Medicine University of Indonesia, Jakarta. The subjects enrolled in this study were 43 infertile women undergoing infertility work-up at the level of diagnostic and/or operative gynecologic endoscopy. They consisted of 31 (72.09%) with endometriosis and 12 (27.91%) with normal laparoscopic finding. The mean ( SD) ages were 32  4 years and 32  3 years in endometriosis and normal patients respectively, while their mean length of menstrual cycles were 31  8 days and 29  1 days in endometriosis and normal patients respectively.
Samples
The endometriotic tissue was obtained by excision during operative laparoscopy procedure, while the endometrium was obtained by biopsy following hysteroscopy procedure prior to laparoscopy. These both procedures were conducted within the periovulatory period (on Day 13-18 of the cycle).
A total of 73 samples was examined, which were divided into six groups, i.e. 12 (16.44%) endometrium of normal patients, 28 (38.36%) endometrium of endometriotic patients, 5 (6.85%) ovary of normal patients, 16 (21.92%) ovary of endometriotic patients, 3 (4.11%) peritoneum of normal patients, and 9 (12.33%) peritoneum of endometriosis patients. This grouping was based on the presence or absence of endometriosis and the tissue site of origin. The accuracy of the tissue type was confirmed by histopathological findings.
Laboratory protocols
After having collected in the operating theatre the tissues were washed with physiologic saline to remove the blood, and then they were immediately sent to the laboratory in cool condition (4 o C). The tissues can be either directly processed for homogenization or stored freeze at minus 20oC before homogenization.
Prior to homogenization the tissues were cleansed and then cut into tiny parts, which were further diluted to 10 times volume in the homogenization buffer. The process of homogenization was performed in a cool condition for 15 minutes. The homogenized tissue was centrifugated for 10 minutes at 1,000 G to separate the supernatant from the tissue matrix. The supernatant was centrifugated for 20 minutes at 10,000 g to separate the big-size protein, such as mitochondria, lysosome, etc. This was followed by the second centrifugation of the supernatant for 2 hours at 100,000 G to precipitate the small-size protein. The upper layer containing the cytosol protein was finally taken to measure its concentration of cytosol fraction protein using Lowry method.
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The receptor concentration was measured quantitatively with enzyme immunosorbent assay (EIA) method using estrogen and progesterone receptor kits (Abbott ER and PR EIA monoclonal, Abbott Laboratories, USA).
Cytosolic receptor calculation
The cytosolic receptor concentration was calculated as sex steroid receptor/cytosol protein (fmol/ml cytosol) using the following formula: 
Statistical analysis
The receptor value was expressed as mean  SE.
Comparisons of the means of receptors were performed by the X 2 -test. The test was stated as significant if the p value is less than 0.05.
RESULTS
Cytosolic estrogen receptor content
The endometrium in normal patients demonstrated 83.33% (10/12 samples) positive value of ERc, with the mean (SE) 608.33 ( 347.09) fmol/mg cytosol protein (Table 1. The endometriotic tissues (ovary and peritoneum) had 64% (16/25 samples) positive value, or 62.5% (10/16) for ovarian samples and 77.78% (7/9) for peritoneal samples respectively, with the mean (SE) ERc concentration in each tissue was 512.99 ( 271.13) and 601.02 ( 232.27) fmol/mg cytosol protein respectively. Table 1 shows clearly that normal tissues contain higher ERc than endometriotic tissues matched with their topographic sites. The ratio of ERc in normal / endometriotic tissues according to their topographic origin are successively 6.13 in endometrium, 4.62 in ovary, and 15.99 in peritoneum. This evident suggests that the ERc highest ratio is expressed by the peritoneum.
Cytosolic progesterone receptor content
The endometrium in normal patients demonstrated 75% (9/12 samples) positive value of PRc, with the mean ( SE) 599.61 ( 383.40) fmol/mg cytosol protein ( Table 2 also shows clearly that the normal tissues contain higher PRc than the endometriotic tissues matched with their topographic sites. The ratio of PRc in the normal/endome triotic tissues according to their topographic origin are successively 28.20 in endometrium, 128.29 in ovary, and 7.64 in peritoneum. This evident suggests that the PRc highest ratio is expressed by the endometrium.
It is appeared that the normal endometrium contains PRc 4.6-folds higher than ERc, whereas the normal ovary contains PRc 27.8-folds higher than ERc. However, the normal peritoneum contains ERc 2.2-folds higher than PRc. 
Significancy comparison between each sex steroid receptor in tissues according to its topographic origin
Significancy test between the sex steroid receptors in endometrium, ovary, and peritoneum of either normal or endometriotic cases showed no significant difference (p>0.05) ( Table 3. and Table 4 ). Table 5 demonstrates that the highest PRc/ERc ratio occurs in the peritoneal tissue. This data suggests that peri-toneum is the most responsive type of sick tissue to the progesterone therapy, while normal ovary is the most af-fected type of normal tissue to the progesterone therapy. 
DISCUSSION
Quantitative versus semi-quantitative assay
Quantitative differences in the expression of estrogen and progesterone receptors between endometriosis and endometrium can be explained by either a difference in the cellular response of the endometriosis to the steroid hormones or a difference in the biological availability of the steroid to the tissue. 12 The receptor content measurement is necessary in determining quantitatively the progress of medical treatment through laboratory methods.
Quantitative assays of cytosolic estrogen receptor (ERc) as well as cytosolic progesterone receptor (PRc) have already been performed by some previous investigators 7, 13 in the different tissue origins, and in the different patients. In this study we have also conducted the similar quantitative assay of the abovementioned receptors (ERc and PRc) in tissues of different topographic origin of the same patients with endometriosis, which are then compared with those from normal patients. This method is not done by the previous investigators.
We found that the content of those steroid receptors in the endometriosis tissue is less than that found in the endometrium of the same patient. More specifically, normal tissues contain higher ERc than endometriotic tis-sues matched with their topographic sites. The ratio of ERc in normal/endometriotic tissues according to their topographic origin are successively 6.13 in endometrium, 4.62 in ovary, and 15.99 in peritoneum. This evident suggests that the ERc highest ratio is expressed by the peritoneum (Table 1) . Moreover, normal tissues con-tained higher PRc than endometriotic tissues matched with their topographic sites. The ratio of PRc in normal/endometriotic tissues according to their topographic origin are successively 28.20 in endometrium, 128.29 in ovary, and 7.64 in peritoneum. This evident suggests that the PRc highest ratio is expressed by the endometrium (Table 2) . Lyndrup et al. 7 have compared the ERc and PRc content in endometriosis and endometrium using receptor assays and histological examinations. They have detected ERc as well as PRc in 64.3% and 100% of cases of endometriosis respectively. Significantly higher values of both ERc and PRc were found in endometrium than endometriosis. A contrast finding was stated by Bergqvist et al. 13 They found that the endometrial receptor concentrations were that same in patients with endometriosis as in the control group because in most cases no receptors could be detected irrespective of the phase of the menstrual cycle.
Interestingly, our results show a lower positive concentration of PRc but a higher positive concentration of ERc compared with the several previous reported studies (Table 7) . This may be caused by the difference in the sites of origin of the samples being studied.
Differences of cytosolic steroid receptor content in endometrium and endometriosis tissues
The concentrations of ERc and PRc in either endometrium or endometriosis tissues are influenced by several factors, including: (1) the phase of menstrual cycle within which the samples are taken; 7, 15, 18 (2) the type of lesion (primary or recurrent), 14 the sites of origin for samples taken (uterine endometrium, peritoneum, or ovary), 7, 15 and the stage of disease (minimal, mild, moderate, severe); (3) the synchronization of sampling (simultaneously, randomly, or at a different time), 15 and (4) the sampling procedures (biopsy, excision; laparoscopically or laparotomically) 15 ( Table 6 ).
The difference of results of ERc as well as PRc in several studies is presented in Table 6 . In the present study we only measure the ERc and PRc in patients with primary endometriosis. Thus, we cannot compare it with recurrent endometriosis. Bergqvist et al 14 have found that in endometriotic tissue, the PRc level was significantly higher in recurrent than in primary endometriotic tissue, but there was no different concerning ERc. The ERc level was significantly lower in ovarian but not in peritoneal endometriosis, compared with that in endometrium. This is in contrast to our data, which demonstrates that in patients with endometriosis the ERc in the peritoneum is higher than that in either the ovary or endometrium in patients with endometriosis. A difference in the number of samples collected might be the explanation (53 in present study versus 69 in their study). Further, they also stated that no difference was seen concerning PRc either in the endometriotic peritoneum or in the normal peritoneum. However, in the present study we have found a contrast difference in PRc concentration in the peritoneum of women with endometriosis (approximately 35 folds higher) when compared with women without endometriosis. N = in cases without endometriosis; E = in cases with endometriosis; SL = significantly low; L = Low; ND = no difference; MP = more pronounced; H = highest; HN = higher but not significant; LN = lower but not significant; PE = higher PRc/ERc ratio; (..) n = reference number; (..) a = present study
The abovementioned discrepancy can be revealed by the explanation of Kitawaki et al. 3 that the endometriosis lesions not only contain ER but also aromatase, an enzyme that catalyzes the conversion of androgens to estrogens. This has suggested that local estrogen production may stimulate the growth of lesions. The expression patterns of ER and PR in endometriotic lesions are different from those in the eutopic endometrium. Moreover, estrogen metabolism, including the expression pattern of aromatase and the regulation of 17 beta-hydroxysteroid dehydrogenase type-2 (an enzyme responsible for the inactivation of estradiol to estrone), is altered in the eutopic endometrium of women with endometriosis, adenomyosis, and/or leiomyomas compared to that in the eutopic endometrium of women without disease.
Our study collected only samples within the midluteal phase of the menstrual cycle in order to obtain uniform samples. On the other hand, Bergqvist et al. 15 have analyzed the levels of ERc and PRc in both endometriotic tissue and endometrium samples collected within different phases of menstrual cycle. They found that steroid cytosolic receptor levels were significantly lower in endometriotic tissue than in endometrium. The differences were most pronounced in follicular phase. In endometrium the ERc and PRc levels varied during the menstrual cycle, being highest in follicular phase. In endometriotic tissue, the estrogen receptor level remained low throughout the cycle. The PRc level increased during the menstrual cycle, being higher in luteal than in follicular phase. This cycle phase pattern was not found in the PRc level. The results show that ER and PR in endometriotic tissue have a different pattern during the menstrual cycle than endometrium and that the PR synthesized is not all biologically active. Their results indicated differences in the hormonal regulation of the two tissue types (endometrium and endometriosis).
As it has been stated earlier, ER and PR can also be measured semiquantitatively using immunohistochemical (IHC) method, which may describe their location and staining intensity in endometrium and endometriotic tissues. This technique had been applied by several investigators. 16, 18, 20, 21 Although it does not produce quantitative results, but it can clarify the receptor status and proliferative activity of eutopic and ectopic endometrium throughout the cycle, and also exclusively differentiate the nature of each type of receptor as stromal, glandular, or epithelial (Table 8) . We did not use this technique in our study because we cannot apply in our future quantitative clinical and laboratory follow-ups. However we agree with the assumption that the IHC technique will be the best choice for a semiquantitative laboratory follow-up during hormonal treatment of endometriosis. Endometriosis lesions: The PRc/ERc ratio in relationship with the prospect of hormonal therapy of endometriosis It is appeared in our study that normal endometrium contained PRc 4.6-folds higher than ERc, whereas the normal ovary contains PRc 27.8-folds higher than ERc. However, the normal peritoneum contains ERc 2.2-folds higher than PRc. It is particularly interested that the significant and highest PRc/ERc ratio occurs in the endometriotic peritoneal tissue (Table 5) , whereas in normal tissue the significant and highest PRc/ERc ratio is found in the ovary. This data may lead us to suggest that peritoneum is the most responsive type of tissue to hormonal (e.g. progesterone) therapy, while the normal ovary is the most concomitantly affected type of normal tissue to progesterone therapy.
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The ratio between PRc and ERc was also considered by Lyndrup et al. 7 and they found significantly higher PRc/ERc ratios in the cytosol of endometriotic tissue. Thus, they concluded that the lower receptor concentrations found in endometriosis cannot be explained solely as ectopic endometrium being diluted by non receptor-containing tissue. In spite of high PRc/ERc ratios in endometriosis, they also encountered significant secretory changes similar to those found in endometrium.
The above revealed facts lead us to estimate that when the abnormal tissue is treated hormonally, no specific response can be obtained. In addition, the hormonal treatment given to the endometriosis patients can also attack the cells in normal tissue because they also contained the similar sex steroid hormone (estrogen and progesterone) receptors. This will particularly affect the peritoneum.
CONCLUSIONS
The ovarian sex steroid (estrogen and progesterone) hormone receptors concentration in the endometriotic tissue is lower than that in the normal tissue, but there is no significant difference of between each tissue according to its same topographic origin.
Our results may assume that the responsivity on hormonal treatment in endometriosis cases will depend on the sex steroid receptor content in the sick tissues, and the peritoneal lesions will possibly give better response than those in other sites. The quantitative method of ERc and PRc measurement might be used a quantitative tool for laboratory follow-ups during hormonal treatment of endometriosis. A further clinical trial is necessary.
